Your browser doesn't support javascript.
Ocular Manifestations of Post-Acute COVID-19 Syndrome, Upper Egypt Early Report.
Tohamy, Dalia; Sharaf, Mohamed; Abdelazeem, Khaled; Saleh, Mohamed G A; Rateb, Mahmoud F; Soliman, Wael; Kedwany, Salma M; Omar Abdelmalek, Mohamed; Medhat, Mohammed A; Tohamy, Amal M; Mahmoud, Hany.
  • Tohamy D; Ophthalmology Department, Assiut University, Assiut, Egypt.
  • Sharaf M; Ophthalmology Department, Assiut University, Assiut, Egypt.
  • Abdelazeem K; Ophthalmology Department, Assiut University, Assiut, Egypt.
  • Saleh MGA; Ophthalmology Department, Assiut University, Assiut, Egypt.
  • Rateb MF; Ophthalmology Department, Assiut University, Assiut, Egypt.
  • Soliman W; Ophthalmology Department, Assiut University, Assiut, Egypt.
  • Kedwany SM; Ophthalmology Department, Assiut University, Assiut, Egypt.
  • Omar Abdelmalek M; Tropical Medicine and Gastroenterology Department, Assiut University, Assiut, Egypt.
  • Medhat MA; Tropical Medicine and Gastroenterology Department, Assiut University, Assiut, Egypt.
  • Tohamy AM; Neuology Department, Assiut University, Assiut, Egypt.
  • Mahmoud H; Ophthalmology Department, Sohag University, Sohag, Egypt.
J Multidiscip Healthc ; 14: 1935-1944, 2021.
Article in English | MEDLINE | ID: covidwho-1334845
ABSTRACT

PURPOSE:

To evaluate the ocular manifestations of post-acute COVID-19 syndrome.

METHODS:

A retrospective, comparative study included 100 patients who had recovered from COVID-19 and 100 controls who were recruited by stratified randomization from hospital registration system and analyzed regarding history, full ophthalmological examination, general examination including internal medicine and neurological evaluation. Laboratory tests were done.

RESULTS:

Mean±SD of age were 55.5 ± 6.2 in COVID group vs 56.5 ± 5.8 in control group; P value = 0.7. In COVID group, 57 patients (57%) were males vs 51 patients (51%) in control group (P value = 0.39), the other compared parameters including history and risk factors showed non-significant difference except for ESR and D-dimer which were elevated in COVID group. In COVID group, 5 patients (5%) were having retinal vascular occlusion, 2 patients (2%) were having anterior ischemic optic neuropathy AION, 3 patients (3%) were having uveitis and 2 patients (2%) were having central serous chorioretinopathy CSCR. While in control group, 2 patients (2%) were having retinal vascular occlusion, and none had AION, uveitis or CSCR (P value = 0.006).

CONCLUSION:

Post-acute COVID-19 syndrome could affect the eyes in the form of coagulation problems, neurological morbidities, and other manifestations. This necessitates meticulous follow-up of recovered patients from COVID-19.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Language: English Journal: J Multidiscip Healthc Year: 2021 Document Type: Article Affiliation country: JMDH.S323582

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Language: English Journal: J Multidiscip Healthc Year: 2021 Document Type: Article Affiliation country: JMDH.S323582